Type 1 interferon deficiency: Biomarker of patients at risk of severe COVID-19. Which patients are more likely to develop a severe form of COVID-19? In a new study, researchers describe a unique and unexpected immunological phenotype in severe and critical patients. Source 1i.
The basis of immunity is for the anitbody to recognize an antigen (A part of the virus). If the body fails to detect it immediately, it could cause serious and grave effects before it can mount a defense. It's like an insider slowly destroying and sabotaging and you don't know who it is making it.
Chronic Fatigue Syndrome a possible long-term effect of COVID-19, experts say. Terri Wilder became dreadfully ill in 2014, falling asleep immediately each day after she got home from work and laying in bed all weekend, recovering just enough to drag herself to work the next week. “I could barely raise my hand to hail a cab,” she said. After nearly two years, Wilder was diagnosed with… Source 1p.
Is the COVID-19 virus pathogenic because it depletes specific host microRNAs? Researchers propose that the COVID-19 virus acts as a microRNA 'sponge' to deplete miRNA levels in ways that aid viral replication and stymie the host immune response. Source 7l.